Today: 9 April 2026
Subscribe
Browse Category

NYSE:OBDC 17 November 2025 - 19 November 2025

Blue Owl Capital (OWL) Scraps OBDC–OBDC II Merger as Redemption Freeze Roils the $3 Trillion Private Credit Market

Blue Owl Capital (OWL) Scraps OBDC–OBDC II Merger as Redemption Freeze Roils the $3 Trillion Private Credit Market

Blue Owl Capital has canceled the planned merger of its two private-credit funds, OBDC and OBDC II, after investor backlash and market volatility. The decision follows a freeze on redemptions at OBDC II and reports that some investors faced potential 20% paper losses if the deal proceeded. Blue Owl shares have dropped over 40% this year. OBDC II aims to reinstate its liquidity program in 2026.
19 November 2025
···
Blue Owl’s BDC Shake‑Up (Nov. 17, 2025): OBDC–OBDC II Merger Puts ~20% Haircut on the Table for Retail Holders—But Double‑Digit Yields Lure Value Buyers

Blue Owl’s BDC Shake‑Up (Nov. 17, 2025): OBDC–OBDC II Merger Puts ~20% Haircut on the Table for Retail Holders—But Double‑Digit Yields Lure Value Buyers

Blue Owl Capital will merge its private OBDC II into the public Blue Owl Capital Corporation (NYSE: OBDC) in an all-stock deal expected to close Q1 2026. OBDC II investors face an implied 20% value loss, as OBDC shares trade at an $11.89 price versus a $14.89 NAV. Both boards approved the deal; OBDC II holders must still vote. Fitch placed OBDC II on Rating Watch Positive after the announcement.
17 November 2025
·

Stock Market Today

  • CONMED Stock Analysis: Growth Outlook and Market Challenges
    April 9, 2026, 1:16 PM EDT. CONMED Corporation (CNMD) shows promising growth potential driven by its diverse surgical product range and strength in General Surgery, including the AirSeal insufflator and Anchor Tissue Retrieval bag. The company projects 19.3% earnings growth for fiscal 2025, maintaining solid performance with an average earnings surprise of 3.71%. Despite a 3.3% stock decline over six months, lagging the S&P 500's 14.3% rise, CNMD remains competitive amid supply chain and data security challenges. The recent 3.6% revenue gain in General Surgery and strategic acquisition of In2Bones Global underscore its growth strategy. However, U.S. sales in the foot and ankle segment may face short-term setbacks due to hurricane disruptions. Investors should weigh these factors when considering CONMED stock retention.

Latest article

Amazon Stock Rises After Andy Jassy Reveals AWS AI Revenue, Defends $200 Billion Spend

Amazon Stock Rises After Andy Jassy Reveals AWS AI Revenue, Defends $200 Billion Spend

9 April 2026
Amazon shares rose 5% Thursday after CEO Andy Jassy revealed AWS’s AI services are generating over $15 billion annually and its chip business more than $20 billion. Jassy said much of AWS’s $200 billion in planned 2026 spending is backed by customer commitments, including a $100 billion OpenAI deal. He also highlighted deep job cuts and a push for smaller teams. Amazon now operates over 1 million robots and plans to launch its Leo satellite network in mid-2026.
Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

Unilever Snaps Up Grüns to Deepen U.S. Wellness Push After McCormick Food Deal

9 April 2026
Unilever said Thursday it will acquire U.S. greens-supplement brand Grüns for an undisclosed sum, with the deal expected to close later this year pending approvals. Grüns was valued at about $500 million in a 2025 Series B round, according to Reuters. The purchase follows Unilever’s recent agreement to combine its food business with McCormick.
Lumentum Stock Nears $960 After JPMorgan, Mizuho Raise Targets on Nvidia AI Optics Demand

Lumentum Stock Nears $960 After JPMorgan, Mizuho Raise Targets on Nvidia AI Optics Demand

9 April 2026
Lumentum shares climbed Thursday after JPMorgan raised its price target to $950, following Mizuho’s hike to $930. The moves come after Nvidia agreed last month to invest $2 billion in Lumentum and make multibillion-dollar purchase commitments. Lumentum reported February quarter revenue of $665.5 million, up 65.5% year-over-year. An SEC filing showed Lumentum will swap 5.7 million shares for $474.6 million in convertible notes.
SBTi Says Corporate Climate Targets Jumped 40% in 2025 as Asia Closes In on Europe

SBTi Says Corporate Climate Targets Jumped 40% in 2025 as Asia Closes In on Europe

9 April 2026
The number of companies with Science Based Targets initiative-validated climate goals reached 9,764 by the end of 2025, up 40% from the previous year. Asia added 1,216 companies, nearly matching Europe’s increase. Europe held 49% of validated targets, Asia 36%, and North America 11%. Japan led single markets with 2,091 companies.
Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Go toTop